CD8A and plasma cell myeloma: An in vivo murine myeloma model showed that low-dose irradiation followed by anti-PD-1 treatment prolonged survival with increased tumor-specific CD8+ T cells, in which both CD4+ and CD8+ T cells were necessary to eliminate MM cells [91].